The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection

Pediatric Nephrology

Volumn 22, Issue 7, 2007, Pages 911-914

  Dragun, Duska ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alloantibodies; Angiotensin II; AT1 receptor; Kidney transplantation; Non HLA antibodies; Vascular rejection

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN ANTAGONIST; HLA ANTIBODY; IMMUNOGLOBULIN; LOSARTAN; LYMPHOCYTE ANTIBODY; RENIN INHIBITOR; STEROID;

ANTIBODY RESPONSE; AUTOIMMUNITY; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG RESPONSE; EDITORIAL; GENETIC CODE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; HYPERTENSION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATORY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALIGNANT HYPERTENSION; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; SURVIVAL TIME; THROMBOSIS; VASCULITIS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIBODIES; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MODELS, IMMUNOLOGICAL; PLASMAPHERESIS; RECEPTOR, ANGIOTENSIN, TYPE 1; TRANSPLANTATION, HOMOLOGOUS;

EID: 34249979842     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0452-z     Document Type: Editorial

References (16)

1. Meier-Kriesche HU, Schold JD, Kaplan B (2004) Long-term renal allograft survival: Have we made significant progress or is it time time to rethink our analytic and therapeutic strategies. Am J Transplant 4:1289-1295
2. Crespo M, Pascual M, Tolkoff-Rubin N, Mauiyyedi S, Fitzpatrick D, Farrell ML, Collins AB, Williams WW, Delmonico FL, Cosimi AB, Colvin RB, Saidmann SL (2001) Acute humoral rejection in renal allograft recipients: Incidence, serology and clinical characteristics. Transplantation 71:652-658
3. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidmann SL, Tolkoff-Rubin N, Williams WW, Delmonico FL, Cosimi AB, Colvin RB (2002) Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classfication. J Am Soc Nephrol 13:779-787
4. Nickeleit V, Vamvakas EC, Pascual M, Poletti BJ, Colvin RB (1998) The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 9:1301-1308
5. Halloran PF, Schlaut J, Solez K, Srinivasa NS (1992) The significance of the anti-class I response II clinical and pathological features of renal transplants with anti-class I-like antibody. Transplantation 53:550-555
6. Vongwiwatana A, Tasanarong A, HIdalgo LG, Halloran PF (2003) The role of B cells and alloantibody in the host response to human organ allograft. Immunol Rev 196:197-218
7. Böhmig G, Exner M, Habicht A, Soleiman A, Schilinger M, Lang U, Hörl WH, Watschinger B, Derfler K, Regele H (2002) Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13:1091-1099
8. Nickeleit V, Mihatsch MJ (2003) Kidney transplants, antibodies and rejection: Is C4d a magic marker? Nephrol Dial Transplant 18:2232-2239
9. Rose M (2004) Role of MHC and non-MHC antibodies in graft rejection. Curr Opin Organ Transplant 9:16-23
10. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y (2001) Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells. Arthritis Rheum 44:1484-1494
11. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G (2005) Angiotensin II type 1-receptor activating antibodies in renal allograft rejection. N Engl J Med 352:558-569
12. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC (1999) Patients with preeclampsia develop agonistic antibodies against the angiotensin AT1 receptor. J Clin Invest 1103:945-952
13. Fu MI, Herlitz H, Schulze W, Wallukat G, Micke P, Eftekhari P, Sjogren KG, Hjalmarson A, Muller-Esterl W, Hoebeke J (2000) Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 18:945-953
14. Mellor AL, Munn DH (2000) Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 18:367-391
15. Dobado Berrios P, Lopez-Pedrera C, Velasco F, Cudrado MJ (2001) The role of tissue factor in the antiphospholipid syndrome. Arthritis Rheum 44:2467-2476
16. Touyz R (2005) Molecular and cellular mechanisms in vascular injury and hypertension: Role of angiotensin II. Curr Opin Nephrol Hypertens 14:125-131